Pharmacokinetic mapping for lesion classification in dynamic breast MRI

Matthias Schabel, Glen R. Morrell, Karen Oh, Cheryl A. Walczak, R. Brad Barlow, Leigh A. Neumayer

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Purpose: To prospectively investigate whether a rapid dynamic MRI protocol, in conjunction with pharmacokinetic modeling, could provide diagnostically useful information for discriminating biopsy-proven benign lesions from malignancies. Materials and Methods: Patients referred to breast biopsy based on suspicious screening findings were eligible. After anatomic imaging, patients were scanned using a dynamic protocol with complete bilateral breast coverage. Maps of pharmacokinetic parameters representing transfer constant (K trans), efflux rate constant (κep), blood plasma volume fraction (υp), and extracellular extravascular volume fraction (υe) were averaged over lesions and used, with biopsy results, to generate receiver operating characteristic curves for linear classifiers using one, two, or three parameters. Results: Biopsy and imaging results were obtained from 93 lesions in 74 of 78 study patients. Classification based on Ktrans and κep gave the greatest accuracy, with an area under the receiver operating characteristic curve of 0.915, sensitivity of 91%, and specificity of 85%, compared with values of 88% and 68%, respectively, obtained in a recent study of clinical breast MRI in a similar patient population. Conclusion: Pharmacokinetic classification of breast lesions is practical on modern MRI hardware and provides significant accuracy for identification of malignancies. Sensitivity of a two-parameter linear classifier is comparable to that reported in a recent multicenter study of clinical breast MRI, while specificity is significantly higher.

Original languageEnglish (US)
Pages (from-to)1371-1378
Number of pages8
JournalJournal of Magnetic Resonance Imaging
Volume31
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Breast
Pharmacokinetics
Biopsy
ROC Curve
Plasma Volume
Multicenter Studies
Neoplasms
Sensitivity and Specificity
Population

Keywords

  • Breast imaging
  • Dynamic contrast-enhanced MRI
  • Tofts model

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Pharmacokinetic mapping for lesion classification in dynamic breast MRI. / Schabel, Matthias; Morrell, Glen R.; Oh, Karen; Walczak, Cheryl A.; Barlow, R. Brad; Neumayer, Leigh A.

In: Journal of Magnetic Resonance Imaging, Vol. 31, No. 6, 2010, p. 1371-1378.

Research output: Contribution to journalArticle

Schabel, Matthias ; Morrell, Glen R. ; Oh, Karen ; Walczak, Cheryl A. ; Barlow, R. Brad ; Neumayer, Leigh A. / Pharmacokinetic mapping for lesion classification in dynamic breast MRI. In: Journal of Magnetic Resonance Imaging. 2010 ; Vol. 31, No. 6. pp. 1371-1378.
@article{41f069f5597e4666bac38c59e34fa339,
title = "Pharmacokinetic mapping for lesion classification in dynamic breast MRI",
abstract = "Purpose: To prospectively investigate whether a rapid dynamic MRI protocol, in conjunction with pharmacokinetic modeling, could provide diagnostically useful information for discriminating biopsy-proven benign lesions from malignancies. Materials and Methods: Patients referred to breast biopsy based on suspicious screening findings were eligible. After anatomic imaging, patients were scanned using a dynamic protocol with complete bilateral breast coverage. Maps of pharmacokinetic parameters representing transfer constant (K trans), efflux rate constant (κep), blood plasma volume fraction (υp), and extracellular extravascular volume fraction (υe) were averaged over lesions and used, with biopsy results, to generate receiver operating characteristic curves for linear classifiers using one, two, or three parameters. Results: Biopsy and imaging results were obtained from 93 lesions in 74 of 78 study patients. Classification based on Ktrans and κep gave the greatest accuracy, with an area under the receiver operating characteristic curve of 0.915, sensitivity of 91{\%}, and specificity of 85{\%}, compared with values of 88{\%} and 68{\%}, respectively, obtained in a recent study of clinical breast MRI in a similar patient population. Conclusion: Pharmacokinetic classification of breast lesions is practical on modern MRI hardware and provides significant accuracy for identification of malignancies. Sensitivity of a two-parameter linear classifier is comparable to that reported in a recent multicenter study of clinical breast MRI, while specificity is significantly higher.",
keywords = "Breast imaging, Dynamic contrast-enhanced MRI, Tofts model",
author = "Matthias Schabel and Morrell, {Glen R.} and Karen Oh and Walczak, {Cheryl A.} and Barlow, {R. Brad} and Neumayer, {Leigh A.}",
year = "2010",
doi = "10.1002/jmri.22179",
language = "English (US)",
volume = "31",
pages = "1371--1378",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Pharmacokinetic mapping for lesion classification in dynamic breast MRI

AU - Schabel, Matthias

AU - Morrell, Glen R.

AU - Oh, Karen

AU - Walczak, Cheryl A.

AU - Barlow, R. Brad

AU - Neumayer, Leigh A.

PY - 2010

Y1 - 2010

N2 - Purpose: To prospectively investigate whether a rapid dynamic MRI protocol, in conjunction with pharmacokinetic modeling, could provide diagnostically useful information for discriminating biopsy-proven benign lesions from malignancies. Materials and Methods: Patients referred to breast biopsy based on suspicious screening findings were eligible. After anatomic imaging, patients were scanned using a dynamic protocol with complete bilateral breast coverage. Maps of pharmacokinetic parameters representing transfer constant (K trans), efflux rate constant (κep), blood plasma volume fraction (υp), and extracellular extravascular volume fraction (υe) were averaged over lesions and used, with biopsy results, to generate receiver operating characteristic curves for linear classifiers using one, two, or three parameters. Results: Biopsy and imaging results were obtained from 93 lesions in 74 of 78 study patients. Classification based on Ktrans and κep gave the greatest accuracy, with an area under the receiver operating characteristic curve of 0.915, sensitivity of 91%, and specificity of 85%, compared with values of 88% and 68%, respectively, obtained in a recent study of clinical breast MRI in a similar patient population. Conclusion: Pharmacokinetic classification of breast lesions is practical on modern MRI hardware and provides significant accuracy for identification of malignancies. Sensitivity of a two-parameter linear classifier is comparable to that reported in a recent multicenter study of clinical breast MRI, while specificity is significantly higher.

AB - Purpose: To prospectively investigate whether a rapid dynamic MRI protocol, in conjunction with pharmacokinetic modeling, could provide diagnostically useful information for discriminating biopsy-proven benign lesions from malignancies. Materials and Methods: Patients referred to breast biopsy based on suspicious screening findings were eligible. After anatomic imaging, patients were scanned using a dynamic protocol with complete bilateral breast coverage. Maps of pharmacokinetic parameters representing transfer constant (K trans), efflux rate constant (κep), blood plasma volume fraction (υp), and extracellular extravascular volume fraction (υe) were averaged over lesions and used, with biopsy results, to generate receiver operating characteristic curves for linear classifiers using one, two, or three parameters. Results: Biopsy and imaging results were obtained from 93 lesions in 74 of 78 study patients. Classification based on Ktrans and κep gave the greatest accuracy, with an area under the receiver operating characteristic curve of 0.915, sensitivity of 91%, and specificity of 85%, compared with values of 88% and 68%, respectively, obtained in a recent study of clinical breast MRI in a similar patient population. Conclusion: Pharmacokinetic classification of breast lesions is practical on modern MRI hardware and provides significant accuracy for identification of malignancies. Sensitivity of a two-parameter linear classifier is comparable to that reported in a recent multicenter study of clinical breast MRI, while specificity is significantly higher.

KW - Breast imaging

KW - Dynamic contrast-enhanced MRI

KW - Tofts model

UR - http://www.scopus.com/inward/record.url?scp=77952852862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952852862&partnerID=8YFLogxK

U2 - 10.1002/jmri.22179

DO - 10.1002/jmri.22179

M3 - Article

VL - 31

SP - 1371

EP - 1378

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 6

ER -